GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PAVM · Jun 30, 2024

PAVmed Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001493152-24-031268General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.31% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1190.60% · OPTIONAL · NOT_ENOUGH_HISTORY

Share-count growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.shares_outstanding

-91.02% · CORE · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

489.76% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

70.17% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-1397.75% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

167.62% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

194.48% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/6 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/8 normalizedLevel 3 Jun 30, 20240/8 normalizedLevel 3 Sep 30, 20245/8 normalizedLevel 3 Dec 31, 20245/6 normalizedLevel 3 Mar 31, 20255/6 normalizedLevel 3 Jun 30, 20255/6 normalizedLevel 3 Sep 30, 20256/6 normalizedLevel 3 Dec 31, 20256/6 normalizedLevel 3 Mar 31, 20266/6 normalizedLevel 3 Jun 30, 20266/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Decreased

Previous: 4.16%
Current: 0.31%
Delta: -3.85%

Cash Generation Increased

Previous: -1297.92%
Current: -1190.60%
Delta: 107.32%

Dilution Increased

Previous: -91.08%
Current: -91.02%
Delta: 0.07%

Growth Increased

Previous: 126.46%
Current: 489.76%
Delta: 363.30%

Inventory Pressure Increased

Previous: 40.59%
Current: 70.17%
Delta: 29.58%

Profitability Decreased

Previous: -1389.70%
Current: -1397.75%
Delta: -8.05%

R And D Intensity Decreased

Previous: 192.18%
Current: 167.62%
Delta: -24.56%

Sbc Intensity Increased

Previous: 186.34%
Current: 194.48%
Delta: 8.15%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · PAVM Fundamental State →Transitioned To · PAVM CASH_GENERATION_INCREASED →Transitioned To · PAVM DILUTION_INCREASED →Transitioned To · PAVM GROWTH_INCREASED →Transitioned To · PAVM INVENTORY_PRESSURE_INCREASED →Transitioned To · PAVM PROFITABILITY_DECREASED →Transitioned To · PAVM R_AND_D_INTENSITY_DECREASED →Transitioned To · PAVM SBC_INTENSITY_INCREASED →Transitioned To · PAVM Fundamental State →Transitioned To · PAVM CAPEX_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.